Order Article Reprints

Peck DS, Lacey JM, White AL, Pino G, Studinski AL, Fisher R, Ahmad A, Spencer L, Viall S, Shallow N, et al. Incorporation of Second-Tier Biomarker Testing Improves the Specificity of Newborn Screening for Mucopolysaccharidosis Type I. International Journal of Neonatal Screening. 2020; 6(1):10. https://doi.org/10.3390/ijns6010010

Peck, Dawn S., Jean M. Lacey, Amy L. White, Gisele Pino, April L. Studinski, Rachel Fisher, Ayesha Ahmad, Linda Spencer, Sarah Viall, Natalie Shallow, and et al. 2020. "Incorporation of Second-Tier Biomarker Testing Improves the Specificity of Newborn Screening for Mucopolysaccharidosis Type I" International Journal of Neonatal Screening 6, no. 1: 10. https://doi.org/10.3390/ijns6010010

Peck, D. S., Lacey, J. M., White, A. L., Pino, G., Studinski, A. L., Fisher, R., Ahmad, A., Spencer, L., Viall, S., Shallow, N., Siemon, A., Hamm, J. A., Murray, B. K., Jones, K. L., Gavrilov, D., Oglesbee, D., Raymond, K., Matern, D., Rinaldo, P., & Tortorelli, S. (2020). Incorporation of Second-Tier Biomarker Testing Improves the Specificity of Newborn Screening for Mucopolysaccharidosis Type I. International Journal of Neonatal Screening, 6(1), 10. https://doi.org/10.3390/ijns6010010